Aeris Capital

GenomeDx discovers, develops, and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care. In partnership with physicians and scientists from leading academic medicine institutions, our mission is to bring cost-effective and high-resolution genomics for routine clinical use in cancer medicine.

Jiff, Inc. is a technology company that specializes in providing a HIPAA-compliant platform for the healthcare industry, enabling the creation of personalized and private communities of care. Founded in 2010 and headquartered in Mountain View, California, Jiff focuses on enhancing communication between healthcare professionals and patients through innovative tools. One of its notable products is JiffPad, an educational platform for iPads that transforms doctor-patient conversations and images into videos, facilitating easier sharing and understanding within the privacy of patients' homes. The company also offers solutions that engage employees by linking company benefits and incentives to healthy behaviors, leveraging familiar wearables and applications. Jiff has formed strategic alliances with firms such as Towers Watson & Co. and Mercer, furthering its mission to improve healthcare delivery and employee engagement. As of April 2017, Jiff operates as a subsidiary of Castlight Health, Inc.

Solstice Biologics LLC is a biotechnology company focused on the development of small cell-permeable RNAi pro-drugs designed for the effective targeting and delivery of nucleic acid therapeutics. Founded in 2012 and located in San Diego, California, the company specializes in creating innovative solutions that enable these therapeutics to penetrate various cell types. By utilizing a small double-stranded cellular RNA to selectively degrade specific mRNAs, Solstice Biologics aims to advance the field of RNA interference (RNAi) and enhance the therapeutic potential of nucleic acid-based treatments.

Affimed NV is a clinical-stage biopharmaceutical company focused on developing innovative cancer immunotherapies. With nearly two decades of expertise in innate immunity, Affimed seeks to leverage the innate immune system to enhance cancer treatment outcomes. The company specializes in discovering and advancing targeted therapies through its unique approach of using innate cell engagers, which aim to address the limitations of existing immuno-oncology therapies. In addition to its core research and development efforts, Affimed also generates revenue by providing research and development services to third parties, utilizing both its own and externally licensed intellectual property.

Jiff, Inc. is a technology company that specializes in providing a HIPAA-compliant platform for the healthcare industry, enabling the creation of personalized and private communities of care. Founded in 2010 and headquartered in Mountain View, California, Jiff focuses on enhancing communication between healthcare professionals and patients through innovative tools. One of its notable products is JiffPad, an educational platform for iPads that transforms doctor-patient conversations and images into videos, facilitating easier sharing and understanding within the privacy of patients' homes. The company also offers solutions that engage employees by linking company benefits and incentives to healthy behaviors, leveraging familiar wearables and applications. Jiff has formed strategic alliances with firms such as Towers Watson & Co. and Mercer, furthering its mission to improve healthcare delivery and employee engagement. As of April 2017, Jiff operates as a subsidiary of Castlight Health, Inc.

Curetis AG is a Germany-based company that specializes in developing molecular diagnostics solutions for infectious diseases. Founded in 2015 and now operating as a subsidiary of OpGen, Inc., Curetis focuses on the detection of pathogens and antibiotic resistance markers. The company offers a rapid diagnostic platform that enables multiparameter testing of various analytes in a single run, providing comprehensive panels for detecting a wide range of pathogens and resistance genes. This innovative approach aims to improve patient outcomes by delivering early, actionable information to healthcare providers, particularly in the context of severe bacterial infections. Curetis's technology not only addresses current healthcare challenges but also presents opportunities for future expansions into other clinical applications beyond infectious diseases.

Butterfly Network, Inc. is a medical imaging company based in Guilford, Connecticut, that specializes in handheld ultrasound technology. Founded in 2011, the company has developed the world's first handheld, single-probe whole-body ultrasound system, known as Butterfly iQ, powered by its proprietary Ultrasound-on-Chip technology. This innovative device provides diagnostic imaging for various medical conditions affecting the cardiac, abdominal, urological, fetal, gynecological, and musculoskeletal systems. Butterfly Network aims to democratize access to medical imaging, particularly for the 4.7 billion people globally who lack access to ultrasound services. By integrating cloud-connected software with its ultrasound hardware, Butterfly enhances the clinical workflow, facilitating earlier detection and remote management of health conditions.

Jiff, Inc. is a technology company that specializes in providing a HIPAA-compliant platform for the healthcare industry, enabling the creation of personalized and private communities of care. Founded in 2010 and headquartered in Mountain View, California, Jiff focuses on enhancing communication between healthcare professionals and patients through innovative tools. One of its notable products is JiffPad, an educational platform for iPads that transforms doctor-patient conversations and images into videos, facilitating easier sharing and understanding within the privacy of patients' homes. The company also offers solutions that engage employees by linking company benefits and incentives to healthy behaviors, leveraging familiar wearables and applications. Jiff has formed strategic alliances with firms such as Towers Watson & Co. and Mercer, furthering its mission to improve healthcare delivery and employee engagement. As of April 2017, Jiff operates as a subsidiary of Castlight Health, Inc.

Affimed NV is a clinical-stage biopharmaceutical company focused on developing innovative cancer immunotherapies. With nearly two decades of expertise in innate immunity, Affimed seeks to leverage the innate immune system to enhance cancer treatment outcomes. The company specializes in discovering and advancing targeted therapies through its unique approach of using innate cell engagers, which aim to address the limitations of existing immuno-oncology therapies. In addition to its core research and development efforts, Affimed also generates revenue by providing research and development services to third parties, utilizing both its own and externally licensed intellectual property.

Smaato Inc. is a global advertising technology company that specializes in real-time advertising solutions for mobile publishers, application developers, and advertisers. Founded in 2005 and headquartered in San Francisco, with additional offices in Hamburg and Singapore, Smaato operates the SPX platform, an enterprise-level ad server that simplifies mobile monetization for its clients. This platform integrates various demand and supply sources, allowing publishers to manage their inventory and utilize first-party data effectively. By connecting quality publishers with premium marketers, Smaato enables clients to enhance their revenue potential and engage audiences across multiple devices.

Sonetik AG is a Swiss company based in Bern that specializes in the development of hearing aids for individuals with hearing impairments. The company offers a range of digital hearing aids under the Sonetik GOhear brand, which includes models designed for various types of hearing loss, such as slightly sloping, steeply sloping, high frequency, and flat losses. Sonetik's approach utilizes preset configurations tailored to the most common patterns of hearing loss, allowing their specialists to match the appropriate hearing aid to the user's specific needs based on hearing test results. This method enables users to achieve similar benefits to those of custom-fitted hearing aids, but at a significantly lower cost, making hearing assistance more accessible. Sonetik AG operates as a subsidiary of Harvard International plc.

Invincea, Inc. is a cybersecurity company based in Fairfax, Virginia, specializing in advanced endpoint security software solutions. Founded in 2006 and originally known as Secure Command, LLC, Invincea rebranded in 2010 and has since positioned itself as a leader in endpoint threat protection, serving over 25,000 customers and 3 million active users across various sectors, including education, finance, healthcare, and utilities. The company's flagship product, X by Invincea, leverages machine learning and behavioral monitoring to detect and neutralize sophisticated cyber threats, such as spear phishing and drive-by downloads, without compromising user productivity. Invincea's innovative technology, which originated from DARPA-funded research, has garnered multiple awards for its effectiveness in countering advanced attacks that evade traditional security measures. Additionally, Invincea collaborates with Dell to provide a customized version of its endpoint security solution for commercial PCs and tablets, further extending its market presence and impact. As of 2017, Invincea operates as a subsidiary of Sophos Group plc.

GenomeDx discovers, develops, and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care. In partnership with physicians and scientists from leading academic medicine institutions, our mission is to bring cost-effective and high-resolution genomics for routine clinical use in cancer medicine.

Atlantium Technologies Ltd., established in 2003, specializes in developing and manufacturing advanced ultraviolet (UV) water treatment solutions for industrial and municipal applications. Its innovative products include medium pressure UV lamps, real-time monitoring software, quartz disinfection chambers, and thick quartz tubes. Atlantium's solutions provide chemical-free disinfection, non-thermal pasteurization, and RO membrane protection, serving clients in aquaculture, bio-pharma, food and beverage, power and energy, and municipal markets. The company's global customer base includes Fortune-500 companies, with strategically placed customer service centers ensuring immediate support. Atlantium's headquarters are in Beit Shemesh, Israel.

Solstice Biologics LLC is a biotechnology company focused on the development of small cell-permeable RNAi pro-drugs designed for the effective targeting and delivery of nucleic acid therapeutics. Founded in 2012 and located in San Diego, California, the company specializes in creating innovative solutions that enable these therapeutics to penetrate various cell types. By utilizing a small double-stranded cellular RNA to selectively degrade specific mRNAs, Solstice Biologics aims to advance the field of RNA interference (RNAi) and enhance the therapeutic potential of nucleic acid-based treatments.

Crescendo Bioscience, Inc. is a molecular diagnostics company specializing in rheumatology, founded in 2002 and located in South San Francisco, California. The company develops quantitative and objective diagnostic tools aimed at assisting rheumatologists in the management of autoimmune and inflammatory diseases. Its primary product, Vectra DA, is a standardized multi-biomarker blood test designed to assess disease activity in rheumatoid arthritis. This test enables rheumatologists to effectively monitor and manage patients by providing critical disease information and insights. Through its innovative diagnostic and prognostic capabilities, Crescendo Bioscience enhances the decision-making process for therapy selection and patient management.

Solstice Biologics LLC is a biotechnology company focused on the development of small cell-permeable RNAi pro-drugs designed for the effective targeting and delivery of nucleic acid therapeutics. Founded in 2012 and located in San Diego, California, the company specializes in creating innovative solutions that enable these therapeutics to penetrate various cell types. By utilizing a small double-stranded cellular RNA to selectively degrade specific mRNAs, Solstice Biologics aims to advance the field of RNA interference (RNAi) and enhance the therapeutic potential of nucleic acid-based treatments.

Affimed NV is a clinical-stage biopharmaceutical company focused on developing innovative cancer immunotherapies. With nearly two decades of expertise in innate immunity, Affimed seeks to leverage the innate immune system to enhance cancer treatment outcomes. The company specializes in discovering and advancing targeted therapies through its unique approach of using innate cell engagers, which aim to address the limitations of existing immuno-oncology therapies. In addition to its core research and development efforts, Affimed also generates revenue by providing research and development services to third parties, utilizing both its own and externally licensed intellectual property.

Nanosolar, Inc. is a manufacturer of solar electricity cells and panels, specializing in cost-efficient solar solutions. Founded in 2001 and headquartered in San Jose, California, with additional manufacturing facilities in Berlin, Germany, Nanosolar develops innovative products such as the Utility Panel, designed for utility-scale power plants, and SolarPly, a lightweight solar-electric cell foil that can be customized in size. The company's proprietary technology involves printing solar cells using CIGS (Copper, Indium, Gallium, Selenium) and nanoparticle inks, along with an annealing process that reduces reliance on expensive vacuum deposition equipment. By leveraging industrial printing methods and roll-to-roll manufacturing, Nanosolar produces solar-electric foil at high speeds, effectively merging the principles of printing with solar photovoltaic semiconductor production, thereby enhancing economic efficiency in the solar industry.

Jiff, Inc. is a technology company that specializes in providing a HIPAA-compliant platform for the healthcare industry, enabling the creation of personalized and private communities of care. Founded in 2010 and headquartered in Mountain View, California, Jiff focuses on enhancing communication between healthcare professionals and patients through innovative tools. One of its notable products is JiffPad, an educational platform for iPads that transforms doctor-patient conversations and images into videos, facilitating easier sharing and understanding within the privacy of patients' homes. The company also offers solutions that engage employees by linking company benefits and incentives to healthy behaviors, leveraging familiar wearables and applications. Jiff has formed strategic alliances with firms such as Towers Watson & Co. and Mercer, furthering its mission to improve healthcare delivery and employee engagement. As of April 2017, Jiff operates as a subsidiary of Castlight Health, Inc.

GenomeDx discovers, develops, and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care. In partnership with physicians and scientists from leading academic medicine institutions, our mission is to bring cost-effective and high-resolution genomics for routine clinical use in cancer medicine.

Crescendo Bioscience, Inc. is a molecular diagnostics company specializing in rheumatology, founded in 2002 and located in South San Francisco, California. The company develops quantitative and objective diagnostic tools aimed at assisting rheumatologists in the management of autoimmune and inflammatory diseases. Its primary product, Vectra DA, is a standardized multi-biomarker blood test designed to assess disease activity in rheumatoid arthritis. This test enables rheumatologists to effectively monitor and manage patients by providing critical disease information and insights. Through its innovative diagnostic and prognostic capabilities, Crescendo Bioscience enhances the decision-making process for therapy selection and patient management.

SynapSense specializes in wireless instrumentation solutions tailored for data centers and large-scale enterprises. Their offerings enable these entities to monitor and optimize their energy consumption, thereby reducing both operational costs and carbon footprint.

Smaato Inc. is a global advertising technology company that specializes in real-time advertising solutions for mobile publishers, application developers, and advertisers. Founded in 2005 and headquartered in San Francisco, with additional offices in Hamburg and Singapore, Smaato operates the SPX platform, an enterprise-level ad server that simplifies mobile monetization for its clients. This platform integrates various demand and supply sources, allowing publishers to manage their inventory and utilize first-party data effectively. By connecting quality publishers with premium marketers, Smaato enables clients to enhance their revenue potential and engage audiences across multiple devices.

Curetis AG is a Germany-based company that specializes in developing molecular diagnostics solutions for infectious diseases. Founded in 2015 and now operating as a subsidiary of OpGen, Inc., Curetis focuses on the detection of pathogens and antibiotic resistance markers. The company offers a rapid diagnostic platform that enables multiparameter testing of various analytes in a single run, providing comprehensive panels for detecting a wide range of pathogens and resistance genes. This innovative approach aims to improve patient outcomes by delivering early, actionable information to healthcare providers, particularly in the context of severe bacterial infections. Curetis's technology not only addresses current healthcare challenges but also presents opportunities for future expansions into other clinical applications beyond infectious diseases.

Smaato Inc. is a global advertising technology company that specializes in real-time advertising solutions for mobile publishers, application developers, and advertisers. Founded in 2005 and headquartered in San Francisco, with additional offices in Hamburg and Singapore, Smaato operates the SPX platform, an enterprise-level ad server that simplifies mobile monetization for its clients. This platform integrates various demand and supply sources, allowing publishers to manage their inventory and utilize first-party data effectively. By connecting quality publishers with premium marketers, Smaato enables clients to enhance their revenue potential and engage audiences across multiple devices.

Coda Automotive builds eco-friendly transportation -- chiefly electric cars -- to create a livable future for generations to come. Headquartered in Southern California, CODA Automotive teamed with American partners to develop an American designed and manufactured electric drivetrain as well as battery system electronics to serve as the foundation for the CODA car. They also partnered with the most highly proficient and advanced companies from around the world, from China to Europe, to build a safe and affordable all-electric car. All the while, CODA Automotive maintained control of brand, design, and critical intellectual property.

Livescribe, Inc. is a technology company based in Oakland, California, specializing in the design and manufacture of smartpens that facilitate the capture, search, and sharing of handwritten notes on digital devices. Founded in 2007, the company offers a range of smartpens, including the Sky Wi-Fi smartpen, which transfers recorded notes and audio to cloud accounts for access on various devices, and the Echo smartpen, which connects to computers via USB for interactive note transfer. Additionally, the Livescribe 3 smartpen utilizes Bluetooth technology to send written data to smartphones and tablets. Livescribe's products cater to a diverse audience, including students, educators, and professionals, aiding them in capturing and sharing their written and auditory experiences. The company also provides associated products such as dot paper, ink, and accessories through online channels. Livescribe operates as a subsidiary of Anoto Group AB.

Coda Automotive builds eco-friendly transportation -- chiefly electric cars -- to create a livable future for generations to come. Headquartered in Southern California, CODA Automotive teamed with American partners to develop an American designed and manufactured electric drivetrain as well as battery system electronics to serve as the foundation for the CODA car. They also partnered with the most highly proficient and advanced companies from around the world, from China to Europe, to build a safe and affordable all-electric car. All the while, CODA Automotive maintained control of brand, design, and critical intellectual property.

Affimed NV is a clinical-stage biopharmaceutical company focused on developing innovative cancer immunotherapies. With nearly two decades of expertise in innate immunity, Affimed seeks to leverage the innate immune system to enhance cancer treatment outcomes. The company specializes in discovering and advancing targeted therapies through its unique approach of using innate cell engagers, which aim to address the limitations of existing immuno-oncology therapies. In addition to its core research and development efforts, Affimed also generates revenue by providing research and development services to third parties, utilizing both its own and externally licensed intellectual property.

Mode Media, founded in Silicon Valley in 2004, is a top 10 U.S. media property with 136 million unique users a month. The company aims to help people discover relevant content by combining human curation with technology that distributes content to the right audience at the right time. Mode Media is focused on building the largest independent premium video and content platform for creators, utilizing distribution and streaming technology to deliver targeted native videos, content, and branded entertainment in real-time. With Mode.com as its owned social networking platform, creators can upload videos and create content stories that are curated by professional editors and personalized through the Mode content algorithm technology. Within six months of its launch, Mode has attracted 31 million unique monthly users and has exceeded 1 billion streamed video views.

Curetis AG is a Germany-based company that specializes in developing molecular diagnostics solutions for infectious diseases. Founded in 2015 and now operating as a subsidiary of OpGen, Inc., Curetis focuses on the detection of pathogens and antibiotic resistance markers. The company offers a rapid diagnostic platform that enables multiparameter testing of various analytes in a single run, providing comprehensive panels for detecting a wide range of pathogens and resistance genes. This innovative approach aims to improve patient outcomes by delivering early, actionable information to healthcare providers, particularly in the context of severe bacterial infections. Curetis's technology not only addresses current healthcare challenges but also presents opportunities for future expansions into other clinical applications beyond infectious diseases.

Smaato Inc. is a global advertising technology company that specializes in real-time advertising solutions for mobile publishers, application developers, and advertisers. Founded in 2005 and headquartered in San Francisco, with additional offices in Hamburg and Singapore, Smaato operates the SPX platform, an enterprise-level ad server that simplifies mobile monetization for its clients. This platform integrates various demand and supply sources, allowing publishers to manage their inventory and utilize first-party data effectively. By connecting quality publishers with premium marketers, Smaato enables clients to enhance their revenue potential and engage audiences across multiple devices.

Tethys BioScience, Inc. is focused on the discovery, development, and commercialization of biological markers for diagnosing metabolic diseases, particularly diabetes. The company has developed the PreDx Diabetes Risk Test, which evaluates a combination of proteins and other blood-borne biomarkers associated with diabetes risk. Founded in 2002, Tethys BioScience is headquartered in Emeryville, California.

Adamas Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of medicines for chronic neurologic disorders. Headquartered in Emeryville, California, the company offers GOCOVRI, an extended-release capsule designed to treat dyskinesia in patients with Parkinson's disease who are undergoing levodopa-based therapy. Adamas is also advancing the development of ADS-5102, currently in Phase III clinical studies targeting walking impairment in patients with multiple sclerosis, and ADS-4101, which has completed Phase I studies for partial onset seizures in epilepsy. Additionally, Adamas provides Namzaric, a combination therapy for moderate to severe Alzheimer's dementia. Founded in 2000, the company operates primarily in the United States, with a focus on addressing healthcare challenges associated with central nervous system disorders.

ConforMIS is a United States-based medical technology company that specializes in developing, manufacturing, and selling joint replacement implants and instruments tailored to each patient's unique anatomy. Utilizing its proprietary iFit Image-to-Implant technology platform, ConforMIS creates personalized knee and hip implants, as well as single-use surgical instruments. The company's offerings include various partial and total knee replacement implants, such as the iTotal CR, iTotal PS, iDuo, and iUni. These products are delivered directly to hospitals and ambulatory surgical centers, ensuring that each implant is individually sized and shaped for optimal fit.

ConforMIS is a United States-based medical technology company that specializes in developing, manufacturing, and selling joint replacement implants and instruments tailored to each patient's unique anatomy. Utilizing its proprietary iFit Image-to-Implant technology platform, ConforMIS creates personalized knee and hip implants, as well as single-use surgical instruments. The company's offerings include various partial and total knee replacement implants, such as the iTotal CR, iTotal PS, iDuo, and iUni. These products are delivered directly to hospitals and ambulatory surgical centers, ensuring that each implant is individually sized and shaped for optimal fit.

mobileo was founded with the aim of "distributing relevant content on the mobile Internet". The company was based in Hamburg (Germany) , and founded by Freddie Geier, former head of Apple Germany. As a main line for its development, mobileo wanted to enable a channel of distribution for content providers on the mobile internet, focusing around a core element, the location. In particular mobileo was very keen on providing a solution for the publishing industry in regards to the challenge of mobility, as well as on allowing the end user to contribute through the sharing of her/his favorite locations. A complete ecosystem was developed consisting of import (and normalization) components, a storage system, a server component, and mobile clients. All along this processing chain, usage was made of an internally developed technology, enabling the expression of relevance (where, when, what) for the content aggregation. This ecosystem was the foundation for both products for external customers, as well as for an own consumer product, GRYD. On the day of the launch of their consumer platform, GRYD, mobileo had to file bankruptcy due to the reason that the investor didn't fulfill is obligations.

Smaato Inc. is a global advertising technology company that specializes in real-time advertising solutions for mobile publishers, application developers, and advertisers. Founded in 2005 and headquartered in San Francisco, with additional offices in Hamburg and Singapore, Smaato operates the SPX platform, an enterprise-level ad server that simplifies mobile monetization for its clients. This platform integrates various demand and supply sources, allowing publishers to manage their inventory and utilize first-party data effectively. By connecting quality publishers with premium marketers, Smaato enables clients to enhance their revenue potential and engage audiences across multiple devices.